Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Postoperative Complications 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulin Resistance 1Hypopituitarism 1Dwarfism, Pituitary 1Dwarfism 1Atherosclerosis 1

Interventions

Metformin 152Clomiphene 52Letrozole 41Inositol 35Folic Acid 18Progesterone 17Exercise 17Ethinyl Estradiol 13Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Contraceptives, Oral 12cetrorelix 11Pioglitazone 10High-Intensity Interval Training 10Cholecalciferol 10Triptorelin Pamoate 9Tablets 9Spironolactone 9Menotropins 8Diet 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7follitropin alfa 6drospirenone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Growth Hormone × Clear all
NCT00518635 2013-02-20

Low Dose Growth Hormone in Obese PCOS Women

Oregon Health and Science University

Phase NA Withdrawn

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡